The performance measure traditionally used in the quality-control (QC) planning process is the probability of rejecting an analytical run when an out-of-control error condition exists. A shortcoming of this performance measure is that it doesn't allow comparison of QC strategies that define analytical runs differently. Accommodating different analytical run definitions is straightforward if QC performance is measured in terms of the average number of patient samples to error detection, or the average number of patient samples containing an analytical error that exceeds total allowable error. By using these performance measures to investigate the impact of different analytical run definitions on QC performance demonstrates that during routine QC monitoring, the length of the interval between QC tests can have a major influence on the expected number of unacceptable results produced during the existence of an out-of-control error condition.
The quality-control (QC) process can be divided into multiple stages [1] . One stage involves QC testing that is triggered by an event such as calibration. The QC test is performed after the event but before any patient samples are analyzed, to determine whether the analytical process is in control. A second stage involves the monitoring of an analytical process over time. In this stage the concept of an analytical run becomes important. In the modern clinical laboratory the definition of an analytical run is often arbitrary. Many times an analytical run is defined in units of time or number of patient specimens between QC samples. The issue of how to define an appropriate run length for routine QC testing has received increased attention recently [2] .
The traditional QC planning process assesses and compares QC strategies on the basis of the probability of rejecting an analytical run when an out-of-control error condition exists (P ed , see Table 1 for a glossary of symbols) and the probability of falsely rejecting an analytical run that is in control (P fr ) [1] . Comparing QC performance by using traditional performance measures is difficult if the definition of an analytical run differs between alternative QC strategies.
As an illustration of the problem, imagine that two clinical laboratories wish to compare their QC performance. The total allowable error specification (TE a ) for the analyte of interest is 5.0 multiples of the analytical SD. Laboratory A tests one control sample per analytical run (N ϭ 1) and rejects the run if the control's result is more than 3.0 analytical SDs from target (1 3s rule). Laboratory B tests two controls per analytical run (N ϭ 2) and rejects if either one is Ͼ2.5 analytical SDs from target (1 2.5s rule). Calculating P fr gives a false-rejection probability of 0.003 for laboratory A and 0.025 for laboratory B. Following the traditional performance evaluation approach, "critical" out-of-control error conditions can be computed as SE c ϭ TE a Ϫ 1.65 for a critical systematic error condition (in multiples of analytical SD) and RE c ϭ TE a /1.96 for a critical increase in analytical imprecision [3] . Calculating P ed at SE c ϭ 3.35 gives an error detection probability of 0.64 for laboratory A and 0.96 for laboratory B. Similar calculations can be performed for RE c . The findings based on traditional performance measures are: Laboratory B uses twice as many control samples per analytical run as laboratory A; laboratory B's false-rejection rate is higher than laboratory A's; and laboratory B has good error detection ability for critical systematic errors, but laboratory A's error detection rate is too low.
Suppose it is then revealed that laboratory A tests one QC sample every 10 patient samples, while laboratory B tests a pair of QC samples every 80 patient samples. Should these different analytical run definitions affect the comparison of the relative QC performance of the two laboratories? Knowledge that laboratory A and laboratory B define their analytical runs differently has no effect on the traditional performance measures P fr and P ed .
The purpose of this paper is to introduce performance measures that can accommodate different definitions of an analytical run. The performance measures are based on the concept of the average number of patient samples (ANP) required to detect an out-of-control error condition. ANP ed will denote the average number of patient specimens from the inception of an out-of-control error condition until it is detected, and ANP fr will denote the average number of patient specimens to rejection when no out-of-control error condition exists.
The clinical laboratory has traditionally specified quality requirements in terms of TE a . Within this context, the performance measures of primary interest should directly relate to the chances that a test result contains an analytical error that exceeds TE a [3] . The average number of patient specimens that contain unacceptable analytical errors resulting from an out-of-control condition will be denoted ANP TE . ANP TE can be separated into two parts. The first part reflects the expected increase in the number of patient specimens with unacceptable analytical errors after the occurrence of an out-of-control condition, but before the next QC testing opportunity has arrived. This part will be denoted ANP E . The second part is the average number of unacceptable results attributable to the out-ofcontrol condition starting from the first QC test after the error. This part will be denoted ANP QE . These performance measures are used to investigate how different analytical run definitions influence QC performance.
Methods
An analytical run will be defined as M patient specimens followed by N control samples. Analytical run definitions with (M, N) equal to (20, 1), (40, 2), and (80, 4) are compared. In each case the ratio of patient specimens to control samples, M/N, is the same. Out-of-control error conditions that cause a systematic error (SE) or an increase in analytical imprecision (RE) are evaluated. Analytical imprecision is assumed to be within-run imprecision. Between-run imprecision is not considered [4] . It is assumed that an out-of-control error condition can occur with equal probability anywhere within the stream of specimens being analyzed and persists until it is detected. QC rules that test only the current group of N control samples are investigated. Two QC rules within this class are evaluated. The 1 ks rule rejects if any of the N control samples in the analytical run are more than k analytical SDs from target. The X(c)/R 4s rule rejects if the average z-score for the N control samples in the analytical run exceeds c SEMs or the range of the z-scores of the N control observations exceeds 4. A z-score is obtained by calculating the difference of a control observation from its expected mean and dividing by its analytical SD. A z-score has a mean value of 0, a SD of 1, and the SEM of N z-score values is 1/͌N. For each analytical run definition, control limits for the 1 ks rule and X(c)/R 4s rule are determined so that ANP fr ϭ 2000 patient samples.
Given M patient specimens per analytical run, ANP fr is equal to the average number of analytical runs to false rejection (ARL fr ) times the number of patient specimens per run, or ANP fr ϭ ARL fr M. Under the assumption that an out-of-control error condition can occur anywhere with equal probability and persists unchanged until de- The magnitude of systematic error that is considered critical.
RE
The increase in analytical imprecision (random error) in test results due to an out-of-control error condition. RE c The magnitude of increase in analytical imprecision that is considered critical.
An analytical run defined as M patient specimens followed by N control samples. 1 ks A QC rule that rejects if any of the control observations in the current analytical run are more than k analytical SDs from target. X (c)/R 4s A QC rule that rejects if the average z-score for the N control observations in the current analytical run exceeds c/͌N or the range of the z-scores exceeds 4. A z-score is obtained by calculating the difference of a control observation from its expected mean and dividing by its analytical SD. ARL ed The average number of analytical runs (average run length) required to detect an out-of-control error condition. ANP ed The average number of patient samples processed from the inception of an out-of-control error condition until it is detected. ARL fr The average number of analytical runs between QC rejections when the process is in control (false rejection). ANP fr The average number of patient samples between QC rejections when the process is in control. ANP E The average number of patient samples with unacceptable analytical errors due to the occurrence of an error condition, but before the next QC testing opportunity. ANP QE The average number of patient samples with unacceptable analytical errors attributable to an out-of-control error condition, starting from the first QC testing opportunity after the occurrence of the error condition. ANP TE The average number of patient samples that contain unacceptable analytical error because of an out-of-control error condition (ANP TE ϭ ANP E ϩ ANP QE ).
tected, a straightforward (but lengthy) mathematical derivation shows that ANP ed is closely approximated by M/2 ϩ M(ARL ed Ϫ 1), where ARL ed denotes the average number of analytical runs to error detection. The first term is the average number of patient specimens after the error condition occurs but before the next QC testing opportunity. The second term is the average number of patient specimens after the first QC testing opportunity until a QC rejection. For QC rules that test only the control samples in the current analytical run, ARL ed ϭ 1/P ed [1] . Alternatively, an analytical run could be defined as T P units of time followed by N control samples [5] . If it is assumed that an out-of-control error condition can occur with equal probability at any point in time and that the number of patient samples analyzed in a given time interval is proportional to the length of the time interval, then the above formula for ANP ed still holds, where M denotes the average number of patient samples processed in T P units of time.
Let P E (SE) represent the probability that a test result contains an analytical error that exceeds TE a during the existence of an out-of-control error condition that causes a systematic error of SE analytical SDs [3] . Then P E (0) is the probability that a test result contains an analytical error that exceeds TE a when the process is in control. The average number of patient samples that contain unacceptable analytical errors attributable to the existence of SE is ANP TE ϭ ANP ed [P E (SE) Ϫ P E (0)], which can be separated into the two components ANP E ϭ (M/2) [P E (SE) Ϫ P E (0)] and ANP QE ϭ M(ARL ed Ϫ 1)[P E (SE) Ϫ P E (0)]. The same equations apply for an out-of-control error condition that causes an increase in analytical imprecision by a factor of RE with P E (SE) and P E (0) replaced by P E (RE) and P E (1) respectively.
All results were obtained by numerical analysis without use of simulations. Given TE a , P E (SE) ϭ 1 Ϫ [⌽(TE a Ϫ SE) Ϫ ⌽(ϪTE a Ϫ SE)] during a systematic error condition equal to SE and P E (RE) ϭ 1 Ϫ [⌽(TE a /RE) Ϫ ⌽(ϪTE a / RE)] if analytical imprecision increases by a factor equal to RE, where ⌽ is the cumulative distribution function of the standard normal distribution. For the 1 ks rule with N control observations, P ed ϭ 1 Ϫ (1 Ϫ P 1 ) N where
is the probability of a single control observation exceeding control limits when a systematic error condition equal to SE exists and P 1 ϭ 1 Ϫ [⌽(k/RE) Ϫ ⌽(Ϫk/RE)] for RE. For the X(c) rule with N control observations, the probability of rejection is P x ϭ 1 Ϫ [⌽(c Ϫ SE͌N) Ϫ ⌽(Ϫc Ϫ SE͌N)] and P x ϭ 1 Ϫ [⌽(c/RE) Ϫ ⌽(Ϫc/RE)] for systematic and random error conditions respectively. For the R 4s rule with N ϭ 2, the probability of rejection, P R , for any systematic error condition is P R ϭ 1 Ϫ 1 2 (8) where 1 2 is the cumulative 2 distribution function with 1 degree of freedom. If a random error condition exists, P R ϭ 1 Ϫ 1 2 (8/RE 2 ). When N Ͼ2, P R is calculated by numerical integration [6] . For the X(c)/R 4s rule, P ed ϭ P x ϩ (1 Ϫ P x )P R . Calculations were performed by using the software package Stata (Stata Corp.). To examine how QC performance is influenced by analytical run definition, we compared three different analytical run lengths while maintaining the same density of control samples to patient specimens. Table 3 shows ANP ed for the Shewhart 1 ks rule with the alternative analytical run definitions. For the 1 ks rule there never appears to be an advantage to defining longer analytical runs with N Ͼ1 if the goal is to minimize the average number of patient specimens processed during the existence of an out-of-control error condition. The advantage of short runs increases as the magnitude of the out-ofcontrol error condition increases. The minimum value that ANP ed will attain is approximately M/2. This occurs when the magnitude of the out-of-control error condition is so large that the probability of a QC rejection is 1.0 at the first QC testing opportunity after the error. Table 4 shows ANP ed for the X(c)/R 4s rule with the three analytical run definitions. When N ϭ 1, the R 4s rule can't be invoked and the X(c)/R 4s rule reduces to a 1 ks rule. Therefore, the (M, N) ϭ (20, 1) columns in Tables 3  and 4 are identical. For RE conditions the performance of the X(c)/R 4s rule is very similar to the 1 ks rule. For SE conditions, the analytical run length with the shortest ANP to rejection for the X(c)/R 4s rule depends on the magnitude of the out-of-control error condition. However, consistent with the case for the 1 ks rule, as the magnitude of the error condition increases, shorter analytical run lengths have a greater chance of early error detection. Figure 1A plots ANP TE for the 1 ks rule as a function of SE for the three different analytical run lengths. Figs. 1B and 1C plot the two components, ANP E and ANP QE , that comprise ANP TE . Note the different scales for the two components. In the patient specimens that are processed after an out-of-control error condition occurs, but before the next QC testing opportunity, the expected number of unacceptable results increases as the magnitude of the out-of-control error condition increases (Fig. 1B) . Longer intervals between QC testing opportunities result in higher expected numbers of unacceptable results. Once a QC testing opportunity arrives, the expected number of unacceptable results caused by an out-of-control error condition depends on how long the error condition exists before it is detected. At this point, the longer analytical run definitions that test a larger group of control samples are associated with lower expected numbers of unacceptable results (Fig. 1C) . Figure 2 plots ANP TE for the 1 ks rule for different TE a requirements. The average number of unacceptable results increases as TE a decreases, but the relative performance of the three different analytical run lengths re-mains the same. Graphs of ANP TE as a function of RE show the same patterns (data not shown). Figure 3 gives ANP TE for the X(c)/R 4s rule for the three analytical run definitions as a function of SE at different TE a specifications. The main difference between ANP TE performance for the X(c)/R 4s rule and the 1 ks rule is when the TE a specification is low and the out-of-control error condition is small. Longer run lengths with N Ͼ1 can produce smaller ANP TE for the X(c)/R 4s rule, whereas there is no benefit to longer run lengths with N Ͼ1 for the 1 ks rule even for small TE a and small error conditions.
Results

Discussion
The probability of rejecting an analytical run when an out-of-control error condition exists is the performance measure that currently guides the QC planning process. On the basis of this performance measure and the TE a requirements, appropriate QC rules and Ns are recommended. For instance, a recent guideline advises a simple Shewhart rule with N ϭ 2 if TE a Ͼ5.65 (SE c Ͼ4), a Shewhart rule or multirule procedure with N ϭ 2 or 3 if 4.65Ͻ TE a Ͻ5.65, Ns of 3 or 4 if 3.65Ͻ TE a Ͻ4.65, and Ns of 4 to 8 if TE a Ͻ3.65 [7] .
Measuring performance in terms of the probability of rejecting an analytical run doesn't permit examination of the influence of different analytical run definitions. Consequently, this issue has not been investigated to any extent in the published literature. Westgard et al. looked at the effect of a number of QC practices, including batch size, on QC performance [8] . They compared "test yield" for increasing batch sizes and concluded that larger batch sizes produced greater test yield. However, test yield is defined in terms of the probability of rejecting analytical runs that are in control or that contain "critical" out-of- Clinical Chemistry 43, No. 11, 1997 control error conditions. Bishop and Nix argue that treating each control sample individually, as if N ϭ 1, provides improved error detection for QC rules designed to detect persistent out-of-control error conditions, such as the 2 2s rule or 4 1s rule [9] .
Different analytical run definitions are easily accommodated if QC performance is measured in terms of ANP ed or ANP TE . Evaluation of these performance measures demonstrates that only in rare cases would less frequent testing of a large group of control samples be preferable to testing fewer control samples more frequently. In situations where it is necessary to improve QC performance, the strategy should be to decrease the interval of time between QC tests, rather than to increase N while keeping the same analytical run length.
We investigated two QC rules (1 ks and X(c)/R 4s ) that are members of the class of QC rules that only test the control samples within a single analytical run. Our findings also apply to the other QC rules within this class. In general, any QC strategy that is based on the periodic testing of control samples will always be vulnerable to producing unacceptable test results during the interval between the occurrence of a large out-of-control error condition and the next QC testing opportunity. Short intervals between QC testing opportunities minimize this vulnerability. To improve QC performance further, strategies that do not depend on the periodic testing of control samples, such as QC methods that use patient results, will be required [10] . While these findings are consistent with intuition, they have never been formally demonstrated because traditional methods of evaluating QC performance have had no way to objectively address the relevant questions.
If patients' results processed after an acceptable QC test are reported as they are obtained, ANP TE will reflect the expected increase in number of unacceptable results reported during the course of an out-of-control error condition. If test results are held in a batch and not reported until a QC test is performed at the end of the batch (sometimes referred to as "bracketing" patient samples by controls), then the unacceptable patient samples that are processed in the batch ending with the QC test that detects the out-of-control error condition will not be reported.
Depending on the stability of an analytical system, most of the time a process should be in control. The overall long-term rate of producing and reporting unacceptable results requires taking into account the frequency of out-of-control error conditions, the type and magnitude of an error condition when it does occur, and knowledge of ANP ed and ANP TE over the range of possible error conditions. In summary, the purpose of this paper has been to investigate the influence of different analytical run definitions on QC performance during the routine monitoring of an analytical process. The performance measures ANP ed and ANP TE provide the ability to investigate this issue in a way that has not been possible with traditional approaches. These performance measures demonstrate that during routine QC monitoring, the length of the interval between QC tests can have a major influence on the expected number of unacceptable patient results produced during the existence of an out-of-control error condition.
